Zai Lab Limited American Depositary Shares (ZLAB) is a publicly traded Healthcare sector company. As of May 21, 2026, ZLAB trades at $18.44 with a market cap of $2.12B and a P/E ratio of -108.98. ZLAB moved +2.29% today. Year to date, ZLAB is +3.98%; over the trailing twelve months it is -42.35%. Its 52-week range spans $15.96 to $44.34. Analyst consensus is strong buy with an average price target of $34.27. Rallies surfaces ZLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ZLAB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $18.44 |
| Market Cap | $2.12B |
| P/E Ratio | -108.98 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.34 |
| 52-Week Low | $15.96 |
| Volume | 151 |
| Avg Volume | 0 |
| Revenue (TTM) | $453.28M |
| Net Income | $-178.12M |
| Gross Margin | 58.00% |
4 analysts cover ZLAB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.27.